Want to join the conversation?
$PM's net cash used in investing activities for 2015 decreased by $288MM to $708MM from last year, due primarily to lower capital expenditures and purchases of businesses in 2014. Capital expenditures fell to $960MM from $1.2Bil. $PM expects capital expenditures in 2016 of about $1.1Bil, to be funded by operating cash flows.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.